Status:
RECRUITING
Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this clinical research study is to learn about the barriers in the real world to accessing treatments for ATC. And to learn about how patients with ATC tolerate and respond to the commerci...
Detailed Description
Primary Objectives: The primary objective of this study is to compare overall survival (OS) between ATC patients treated at MDA versus outside of MDA using treatment regimens offered at MDA based on ...
Eligibility Criteria
Inclusion
- All adult patients aged 18 years or older with anaplastic thyroid cancer or poorly differentiated thyroid cancer as their clinical and/ or histological diagnosis will be included.
Exclusion
- Patients who do not have anaplastic thyroid cancer or poorly differentiated thyroid cancer on their tumor tissue would be excluded.
Key Trial Info
Start Date :
December 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2034
Estimated Enrollment :
459 Patients enrolled
Trial Details
Trial ID
NCT06507878
Start Date
December 5 2024
End Date
July 1 2034
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030